🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Since measles-mumps-rubella (MMR) and varicella vaccinations are establishe...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04
Trial ID
NCT00352898
Treatments Being Tested
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
This study was conducted to obtain safety and immunogenicity data after a b...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01245751
Treatments Being Tested
This study is a Phase 3, randomized, modified double-blind study which aims...
Status
Active Not Recruiting
Location
Investigational Site Number : 0560004
Start Date
2025-05-22
Trial ID
NCT06975878
Treatments Being Tested
The study is being conducted to demonstrate that V221 may be administered c...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00109343
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-02-06
Trial ID
NCT01506193
Treatments Being Tested
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Completed
Location
Hvidovre Hospital ( Site 0003)
Start Date
2019-08-28
Trial ID
NCT04016714
Treatments Being Tested
The purpose of this observer blinded study is to provide information on vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-20
Trial ID
NCT00578175
Treatments Being Tested
Hepatitis A vaccine will be given either alone or together with measles, mu...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00312858
This study will compare the safety and immunogenicity of ZOSTAVAX™ (V211) a...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01385566